The latest report from Reports and Data reveals that the global Intravenous (IV) Solutions Market reached USD 7.8 billion in 2022, with an anticipated revenue Compound Annual Growth Rate (CAGR) of 4.8% over the forecast period.
Intravenous fluid regulation involves managing the volume of fluid administered intravenously into the bloodstream via a tube connected to a bag. This tube is inserted into a vein, and the fluids used in such treatments consist of water, electrolytes, sugar, and nutrients, with concentrations tailored to the patient’s physiological needs. IV solutions find extensive application in hospitals and clinics, serving to address chronic conditions and provide hydration and nourishment for patients unable to consume food or liquids orally.
The utilization of IV solutions in emergency scenarios for the rapid delivery of medications and fluids to critically ill patients is on the rise. Additionally, the escalating incidence of accidents and injuries, particularly in emerging economies, contributes to the market’s revenue growth. IV solutions are routinely employed to maintain hydration and electrolyte balance during and after surgical procedures.
Access Free sample PDF Copy of the Report @
Moreover, the increasing adoption of IV solutions in home healthcare settings is expected to bolster revenue growth. With a growing aging population and a rising demand for home healthcare, IV solutions are regularly employed for administering medication and nutrition to individuals confined to their residences. The increasing trend toward self-administered intravenous therapies is poised to further drive the demand for IV solutions.
Key players in the Intravenous (IV) Solutions Market:
- Baxter International Inc.
- B. Braun Melsungen AG
- Fresenius SE & Co. KGaA
- Grifols S.A.
- ICU Medical, Inc.
- Sichuan Kelun Pharmaceutical Co., Ltd.
- Terumo Corporation
- Sino-Swed Pharmaceutical Corp. Ltd.
- JW Life Science
- Otsuka Pharmaceutical Factory, Inc.
Some Key Highlights in the Report:
- In 2022, the dominant revenue share in the global market for intravenous (IV) solutions was held by the crystalloid segment. This can be attributed to the extensive use of crystalloids as the primary IV solutions within the medical field. Crystalloids are essentially water-based solutions that contain important electrolytes like sodium, chloride, and potassium. They are frequently employed to address issues related to electrolyte imbalances and dehydration. Furthermore, crystalloid solutions are commonly administered to patients who have experienced fluid loss due to trauma or blood loss. These solutions are available in various concentrations, including isotonic, hypotonic, and hypertonic, to cater to diverse medical requirements.
- Looking ahead, the fluid and electrolyte balancing segment is projected to experience the highest growth rate in revenue within the global IV solutions market during the forecast period. These solutions are utilized to rehydrate patients suffering from dehydration or those who have lost fluids due to conditions like vomiting, diarrhea, or excessive sweating, all while maintaining their electrolyte balance. IV fluids are also used to treat patients with renal problems or individuals unable to consume fluids orally due to surgical procedures or other medical complications.
- In 2022, the North American market accounted for the largest share of revenue in the global IV solutions market. This can be attributed to the increasing prevalence of chronic illnesses such as cancer, diabetes, and cardiovascular diseases in the region. Moreover, the rising demand for home healthcare services is expected to drive revenue growth in this area.
- During the forecast period, the European market is anticipated to witness the swiftest revenue growth rate in the global IV solutions market. This growth is primarily due to an aging population and the higher incidence of chronic illnesses within the region. Additionally, the robust healthcare infrastructure and increased investment in research and development are poised to contribute to the market’s revenue growth in this geographical area.
Get in detailed Research Study @ https://www.reportsanddata.com/report-detail/intravenous-solutions-market
For the purpose of this report, Reports and Data has segmented the global Intravenous (IV) solutions market on the basis of Product Type Outlook, Application Outlook, End-use Outlook, and Regional Outlook:
Product Type Outlook (Revenue, USD Billion; 2022 – 2032)
- Other Types
Application Outlook (Revenue, USD Billion; 2022 – 2032)
- Fluid & Electrolyte Balance
- Nutritional Support
- Blood Transfusion
- Other Applications
End-use Outlook (Revenue, USD Billion; 2022 – 2032)
- Ambulatory Surgical Centers (ASCs)
Download Summary @ https://www.reportsanddata.com/download-summary-form/6388
Regional Outlook (Revenue, USD Billion; 2022-2032)
- North America
- Rest of Europe
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/6388
Some points on how the report benefits stakeholders:
- The reports include historical (2020–2021) and forecast (2022–2032) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
- Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2019 and 2030.
- The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
- The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
- Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
- The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.
Explore Latest Trending Research Reports By Reports and Data’s
Concussion Market, By Type (Mild, Moderate, and Severe), By Diagnosis (Imaging Tests, Neurological Evaluation, and Others), By Treatment (Medications, Therapy, and Surgery), By End-use (Hospitals, Clinics, and Others), and By Regional Forecast to 2032
High Resolution Melting Analysis Market, By Product Type (Instruments, Reagents and Consumables, and Software), By Application (Diagnostics, Epigenetics, Mutation Detection, and Other Applications), and By Region Forecast to 2032
Hypodermic Needle Market, By Type (Standard Hypodermic Needles, Safety Hypodermic Needles, and Others), By Application (Therapeutic Injections, Vaccination Injections, and Others), and By Region Forecast to 2032
Immunoinformatics Market, By Product Type (Tools and Services), By Application (Vaccine Design, Drug Discovery, and Immune System Analysis), and By Region Forecast to 2032
Implantable Cardiac Monitor Market, By Type (Single-Lead, Dual-Lead, and Multi-Lead), By Application (Atrial Fibrillation, Bradycardia, Tachycardia, and Others), and By Region Forecast to 2032
Implantable Drug Delivery Devices Market, By Product Type (Biodegradable and Non-biodegradable), By Drug Release Mechanism (Continuous and Programmable), By Application, By End-Use, and By Region Forecast to 2032
Implantable Loop Recorders Market, By Product Type (Traditional and Advanced) By End-Use (Clinics and Ambulatory Surgical Centers) By Application, And By Region Forecast To 2032
Implantable Medical Device Market, By Product Type (Cardiovascular, Orthopedic, Dental, Neurostimulation, and Others), By End-Use (Hospitals, Clinics, and Research Institutes), and By Region Forecast to 2032
In Vitro Transcription Template Market, By Product Type (DNA, RNA, and Others), By Application (Research, Diagnostics, Therapeutics, and Others), and By Region Forecast to 2032
Indirect Calorimeter Market, By Product Type (Desktop and Portable), By Application (Clinical Diagnostics, Sports & Fitness, and Research), and By Region Forecast to 2032
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-intravenous-solutions-market